Cargando…

Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis

BACKGROUND: Claudin-1 plays an important part in maintaining the mucosal structures and physiological functions. Several studies showed a relationship between claudin-1 and colorectal cancer (CRC), but its prognostic significance is inconsistent. This meta-analysis assessed the prognostic value and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Didi, Zhang, Jiantao, Liu, Tao, Li, Chao, Ning, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443231/ https://www.ncbi.nlm.nih.gov/pubmed/32855635 http://dx.doi.org/10.1155/2020/4258035

Ejemplares similares

Corrigendum to “Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis”
por: Zuo, Didi, et al.
Publicado: (2020)

Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis
por: Li, Chao, et al.
Publicado: (2019)

Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Chao, et al.
Publicado: (2019)

Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Chao, et al.
Publicado: (2018)

Construction and validation of a metabolic risk model predicting prognosis of colon cancer
por: Zuo, Didi, et al.
Publicado: (2021)

Prognostic value of tumour microenvironment‐related genes by TCGA database in rectal cancer
por: Li, Chao, et al.
Publicado: (2021)

Prognostic and clinical significance of claudin-4 in gastric cancer: a meta-analysis
por: Liu, Jin-xin, et al.
Publicado: (2015)

Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer
por: You, Jie, et al.
Publicado: (2016)

Claudin-9 is a novel prognostic biomarker for endometrial cancer
por: Endo, Yuta, et al.
Publicado: (2022)

Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis
por: Jiang, Yangyan, et al.
Publicado: (2015)

Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis
por: Jiang, Yangyan, et al.
Publicado: (2016)

SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer
por: Gan, Caiqin, et al.
Publicado: (2023)

Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer
por: Yang, Linqi, et al.
Publicado: (2022)

Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer
por: Rui, Tao, et al.
Publicado: (2022)

The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2023)

TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer
por: Wei, Bingbing, et al.
Publicado: (2017)

PBX1 is a valuable prognostic biomarker for patients with breast cancer
por: Ao, Xiang, et al.
Publicado: (2020)

Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer
por: KARABULUT, MEHMET, et al.
Publicado: (2015)

TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis
por: Zhong, Yucheng, et al.
Publicado: (2017)

Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer
por: Li, Jinyun, et al.
Publicado: (2017)

Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern
por: Tabariès, Sébastien, et al.
Publicado: (2021)

Comment on “Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis”
por: Wang, Bolin, et al.
Publicado: (2019)

Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis
por: Georges, Rania, et al.
Publicado: (2012)

Response to Comment on “Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis”
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Emerging clinical significance of claudin-7 in colorectal cancer: a review
por: Wang, Kun, et al.
Publicado: (2018)

Antibody targeting of claudin-1 as a potential colorectal cancer therapy
por: Cherradi, S., et al.
Publicado: (2017)

Expression and Clinical Significance of Claudin-7 in Patients With Colorectal Cancer
por: Xu, Chang, et al.
Publicado: (2018)

Expression patterns of claudins in cancer
por: Tao, Daoyu, et al.
Publicado: (2023)

Comprehensive analysis of expression and prognostic value of the claudin family in human breast cancer
por: Yang, Guangda, et al.
Publicado: (2021)

Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer
por: Seo, Kyung Won, et al.
Publicado: (2010)

Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer
por: Kojima, Manabu, et al.
Publicado: (2020)

Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
por: Rui, Yuan-Yi, et al.
Publicado: (2013)

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
por: Liu, Yi, et al.
Publicado: (2013)

A Systematic Review and Meta-Analysis of Diagnostic and Prognostic Serum Biomarkers of Colorectal Cancer
por: Liu, Zhongyu, et al.
Publicado: (2014)

The prognostic value of proliferating cell nuclear antigen expression in colorectal cancer: A meta-analysis
por: Zhou, He, et al.
Publicado: (2018)

Claudin-7 promotes the epithelial – mesenchymal transition in human colorectal cancer
por: Philip, Rahel, et al.
Publicado: (2014)

Claudin18.who? Examining biomarker overlap and outcomes in claudin18.2-positive gastroesophageal adenocarcinomas
por: Klempner, S.J., et al.
Publicado: (2023)

A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients
por: Gowrikumar, Saiprasad, et al.
Publicado: (2021)

Claudin and pancreatic cancer
por: Wang, Chen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_acgak4o2dv8ck1398fkhsv7c21